E24.2

Drug-induced Cushing's syndrome

Billable / specific

E24.2 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.

Inclusion terms

Includes (from E24)

  • Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.

Excludes1

Not coded here — never report together with this code.

  • transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E24)
  • galactorrhea (N64.3) (from E24)
  • gynecomastia (N62) (from E24)
  • congenital adrenal hyperplasia (E25.0) (from E24)

Use additional code

Add a code to identify the following, if applicable.

  • code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)

Also known as

  • Cushingoid due to steroid therapy
  • Cushing's, syndrome or disease, drug-induced
  • Cushing's, syndrome or disease, iatrogenic
  • Hyperadrenocorticism, iatrogenic
  • Hypercorticosteronism
  • Hypercortisonism
  • Steroid, effects, cushingoid
  • Syndrome, Cushing's, due to drugs
  • Syndrome, Cushing's, drug-induced

Parent code

  • E24Cushing's syndromeHeader

Related codes

  • E24.0Pituitary-dependent Cushing's diseaseBillable
  • E24.1Nelson's syndromeBillable
  • E24.3Ectopic ACTH syndromeBillable
  • E24.4Alcohol-induced pseudo-Cushing's syndromeBillable
  • E24.8Other Cushing's syndromeBillable
  • E24.9Cushing's syndrome, unspecifiedBillable

Browse